Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and -5

Molecular Endocrinology

Volumn 21, Issue 5, 2007, Pages 1246-1257

  Laursen, Lisbeth S ^a   Kjaer Sorensen, Kasper ^a   Andersen, Mikkel H ^a   Oxvig, Claus ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE FRAGMENT; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN RECEPTOR;

ARTICLE; CELL SURFACE; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REGULATORY MECHANISM;

CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; KIDNEY; KINETICS; PEPTIDE HYDROLASES; PHOSPHORYLATION; RECEPTORS, SOMATOMEDIN; SOMATOMEDINS;

EID: 34250880671     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2006-0522     Document Type: Article

References (48)

1. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT, 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
2. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
3. Holly J, Perks C 2006 The role of insulin-like growth factor binding proteins. Neuroendocrinology 83:154-160
4. Bunn RC, Fowlkes JL 2003 Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab 14:176-181
5. Payet LD, Wang XH, Baxter RC, Firth SM 2003 Amino-and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions. Endocrinology 144:2797-2806
6. Yan X, Forbes BE, McNeil KA, Baxter RC, Firth SM 2004 Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation. J Biol Chem 279:53232-53240
7. Imai Y, Moralez A, Andag U, Clarke JB, Busby WH, Clemmons DR 2000 Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J Biol Chem 275:18188-18194
8. Shand JH, Beattie J, Song H, Phillips K, Kelly SM, Flint DJ, Allan GJ 2003 Specific amino acid substitutions determine the differential contribution of the N- and Cterminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding IGF-I. J Biol Chem 278:17859-17866
9. Zeslawski W, Beisel HG, Kamionka M, Kalus W, Engh RA, Huber R, Lang K, Holak TA 2001 The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5. EMBO J 20:3638-3644
10. Headey SJ, Keizer DW, Yao S, Brasier G, Kantharidis P, Bach LA, Norton RS 2004 C-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-II. Mol Endocrinol 18:2740-2750
11. Siwanowicz I, Popowicz GM, Wisniewska M, Huber R, Kuenkele KP, Lang K, Engh RA, Holak TA 2005 Structural basis for the regulation of insulin-like growth factors by IGF binding proteins. Structure (Camb) 13:155-167
12. Sitar T, Popowicz GM, Siwanowicz I, Huber R, Holak TA 2006 Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc Natl Acad Sci USA 103:13028-13033
13. Kalus W, Zweckstetter M, Renner C, Sanchez Y, Georgescu J, Grol M, Demuth D, Schumacher R, Dony C, Lang K, Holak TA 1998 Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions. EMBO J 17:6558-6572
14. Boldt HB, Overgaard MT, Laursen LS, Weyer K, Sottrup-Jensen L, Oxvig C 2001 Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin. Biochem J 358:359-367
15. Oxvig C, Overgaard MT, Sottrup-Jensen L 2004 Pappalysin-1 (pregnancy-associated plasma protein-A). In: Barrett AJ, Rawlings ND, Woessner JF, eds. Handbook of proteolytic enzymes. 2nd ed. London: Academic Press; 754-757
16. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR, Conover CA 1999 The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96:3149-3153
17. Laursen LS, Overgaard MT, Soe R, Boldt HB, Sottrup-Jensen L, Giudice LC, Conover CA, Oxvig C 2001 Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 504:36-40
18. Laursen LS, Overgaard MT, Nielsen CG, Boldt HB, Hopmann KH, Conover CA, Sottrup-Jensen L, Giudice LC, Oxvig C 2002 Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis. Biochem J 367:31-40
19. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
20. Nam TJ, Busby WH, Rees C, Clemmons DR 2000 Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. Endocrinology 141:1100-1106
21. Nam T, Moralez A, Clemmons D 2002 Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions. Endocrinology 143:30-36
22. Ning Y, Schuller AG, Bradshaw S, Rotwein P, Ludwig T, Frystyk J, Pintar JE 2006 Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5. Mol Endocrinol 20:2173-2186
23. Rajaram S, Baylink DJ, Mohan S 1997 Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18:801-831
24. Okazaki R, Riggs BL, Conover CA 1994 Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells. Endocrinology 134:126-132
25. Liu XJ, Ling N 1993 Regulation of IGFBP-4 and -5 expression in rat granulosa cells. Adv Exp Med Biol 343:367-376
26. Duan C, Clemmons DR 1998 Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells. J Biol Chem 273:16836-16842
27. Duan C 2002 Specifying the cellular responses to IGF signals: roles of IGF-binding proteins. J Endocrinol 175:41-54
28. Conover CA, Bale LK, Overgaard MT, Johnstone EW, Laursen UH, Fuchtbauer EM, Oxvig C, van Deursen J 2004 Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 131:1187-1194
29. Conover CA, Faessen GF, Ilg KE, Chandrasekher YA, Christiansen M, Overgaard MT, Oxvig C, Giudice LC 2001 Pregnancy-associated plasma protein-a is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum. Endocrinology 142:2155-2158
30. Bayes-Genis A, Schwartz RS, Lewis DA, Overgaard MT, Christiansen M, Oxvig C, Ashai K, Holmes Jr DR, Conover CA 2001 Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler Thromb Vasc Biol 21:335-341
31. Forbes BE, Hartfield PJ, McNeil KA, Surinya KH, Milner SJ, Cosgrove LJ, Wallace JC 2002 Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis. Eur J Biochem 269:961-968
32. Laursen LS, Overgaard MT, Weyer K, Boldt HB, Ebbesen P, Christiansen M, Sottrup-Jensen L, Giudice LC, Oxvig C 2002 Cell surface targeting of pregnancy-associated plasma protein-A proteolytic activity. Reversible adhesion is mediated by two neighboring short consensus repeats. J Biol Chem 277:47225-47234
33. Weyer K, Overgaard MT, Laursen LS, Nielsen CG, Schmitz A, Christiansen M, Sottrup-Jensen L, Giudice LC, Oxvig C 2004 Cell surface adhesion of pregnancy-associated plasma protein-A is mediated by four clusters of basic residues located in its third and fourth CCP module. Eur J Biochem 271:1525-1535
34. Overgaard MT, Boldt HB, Laursen LS, Sottrup-Jensen L, Conover CA, Oxvig C 2001 Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. J Biol Chem 276:21849-21853
35. Mohan S, Thompson GR, Amaar YG, Hathaway G, Tschesche H, Baylink DJ 2002 ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Biochemistry 41:15394-15403
36. Busby WH, Nam TJ, Moralez A, Smith C, Jennings M, Clemmons DR 2000 The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium. J Biol Chem 275:37638-37644
37. Jones JI, Gockerman A, Busby Jr WH, Camacho-Hubner C, Clemmons DR 1993 Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 121:679-687
38. Miyakoshi N, Qin X, Kasukawa Y, Richman C, Srivastava AK, Baylink DJ, Mohan S 2001 Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. Endocrinology 142:2641-2648
39. Headey SJ, Keizer DW, Yao S, Wallace JC, Bach LA, Norton RS 2004 Binding site for the C-domain of insulinlike growth factor (IGF) binding protein-6 on IGF-II; implications for inhibition of IGF actions. FEBS Lett 568:19-22
40. Carrick FE, Hinds MG, McNeil KA, Wallace JC, Forbes BE, Norton RS 2005 Interaction of insulin-like growth factor (IGF)-I and -II with IGF binding protein-2: mapping the binding surfaces by nuclear magnetic resonance. J Mol Endocrinol 34:685-698
41. Marshall CJ 1995 Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185
42. Ewton DZ, Florini JR 1995 IGF binding proteins-4, -5 and -6 may play specialized roles during L6 myoblast proliferation and differentiation. J Endocrinol 144:539-553
43. James PL, Stewart CE, Rotwein P 1996 Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. J Cell Biol 133:683-693
44. Kumar A, Mohan S, Newton J, Rehage M, Tran K, Baylink DJ, Qin X 2005 Pregnancy-associated plasma protein-A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism. J Biol Chem 280:37782-37789
45. Overgaard MT, Haaning J, Boldt HB, Olsen IM, Laursen LS, Christiansen M, Gleich GJ, Sottrup-Jensen L, Conover CA, Oxvig C 2000 Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 275:31128-31133
46. Glerup S, Boldt HB, Overgaard MT, Sottrup-Jensen L, Giudice LC, Oxvig C 2005 Proteinase inhibition by proform of eosinophil major basic protein (pro-MBP) is a multistep process of intra- and intermolecular disulfide rearrangements. J Biol Chem 280:9823-9832
47. Laursen LS, Oxvig C 2005 Real-time measurement in living cells of insulin-like growth factor activity using bioluminescence resonance energy transfer. Biochem Pharmacol 69:1723-1732
48. Qin QP, Christiansen M, Oxvig C, Pettersson K, Sottrup-Jensen L, Koch C, Norgaard-Pedersen B 1997 Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome. Clin Chem 43:2323-2332